Agoracom Blog Home

Posts Tagged ‘CSE’

North Shore Campaign on the Julie Nickel-Pge Project & Corporate Update

Posted by AGORACOM-JC at 2:24 PM on Friday, July 25th, 2014

 

Montreal, Quebec / July 25, 2014 – St-Georges Platinum and Base Metals Ltd. (OTCQX: SXOOF) (CSE: SX) (BSE: 85G1) is pleased to update its shareholders on exploration efforts on its Julie Nickel & PGE project on Quebec’s North Shore and on other corporate matters.

Julie Nickel & PGE Project 2014 Campaign

St-Georges‘ personnel has started to work on planning and permitting for a drilling campaign. This campaign is designed to test 75-100 metres of depth within a block 1,500 metres long by 200 metres wide within the previously identified 1.5 km corridor of sulphide impregnated rock that has been mapped at surface. The Company is expecting to complete the surface sampling and channelling campaign initiated last year along the 1.5 km identified sulphide rich zone.

This program will sample large sections of the remaining 10 km electromagnetic conductor located within an identified mafic unit which coincides with a few sulphide rich outcrops of interest. Large sections of the sulphide rich outcrop will be investigated through channel sampling and a tight grid that encompasses the 1.5 km corridor already identified. Random samples will be collected from outcrops during mapping traverses. A gravimetric survey is also proposed for this area to further define targets.

Shongwa & Mwinilunga; Proposed Acquisition in Zambia

As announced earlier, the Company has completed all title verification on the proposed Zambian transaction.

However, technical due diligence has been hampered by delays in acquisition of supporting data related to reports and information initially delivered to us by the vendor. The Definitive Feasibility Study commissioned by the vendor, Kasni Investment Limited in 2013, makes certain claims regarding the existence of a very large mineral resource and we have failed so far to find the evidence supporting the existence of any size of mineral resource. The Company has no firm timetable as to when or whether the necessary data will be delivered and allow the completion of the due diligence. Therefore, a definitive closing, if any, for this proposed transaction is impossible to predict.

Initial announcement of the proposed Zambian Transaction in February provided the Company with additional offers similar in size and grade to the original project. In a few cases these offers are similar or better entry points for St-Georges than the original. The Company is reviewing the potential for acquisition of near production projects in Zambia, Namibia and in South Africa.

Other Transactions

Firming up in Nickel prices and renewed interest for the commodity has triggered new interest for nickel projects. The Balmoral Resources (BAR on the TSX) discovery earlier this year of 45.28 metres grading 1.79% nickel, 0.19% copper, 0.42 g/t platinum and 1.04 g/t palladium has also contributed to renewed interest in high grade nickel projects in Quebec. St-Georges has been contacted by groups looking to enter the nickel exploration field and the Company has initiated discussions to sell or joint venture some of the projects that it owns in Quebec. For comparison purpose only, the 2011 surface campaign on the Julie Nickel & PGE Project yielded an average of 1.78% nickel and 0.33% copper from select surface samples collected within the above described 1.5 km sulphide rich zone identified as the Julie Corridor.

ON BEHALF OF THE BOARD OF DIRECTORS

Wei Tek Tsai

Wei Tek Tsai, Director

Joel Scodnick, P.GEO, St-Georges’ VP Exploration, Qualified Person under National Instrument 43-101 has reviewed the content of this press release.

About St-Georges

St-Georges is a Platinum-Palladium & Nickel explorer with projects in the Province of Quebec, Canada. Headquartered in Montreal, the Company’s stock is listed on the CSE under the symbol SX, on the OTCQX under the Symbol SXOOF and on the Berlin Stock Exchange under the symbol 85G1. Its Flagship project is the Julie Nickel-Cobalt & Platinum Project on Quebec’s North Shore near the deep-seaport town of Baie-Comeau. For additional information, please visit our website at www.stgeorgesplatinum.com.

Forward-looking Statement:

This document contains certain forward-looking statements which involve known and unknown risks, delays, and uncertainties not under the corporation’s control which may cause actual results, performance or achievements of the corporation to be materially different from the results, performance or expectation implied by these forward-looking statements.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Enertopia Announces AGM Results

Posted by AGORACOM-JC at 8:06 AM on Wednesday, July 23rd, 2014

 

Vancouver, BC /July 23 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce all resolutions were approved and adopted at its Annual General Meeting (AGM) held on July 15th.

Re-election of directors was approved with the following results:

Nominee For Withhold Not Voted
Robert McAllister 18,929,105 (99.41%) 113,264 (0.59%) 11,529,448
Donald Findlay 18,963,169 (99.58%) 79,200 (0.42%) 11,529,448
John Thomas 19,000,854 (99.78%) 41,515 (0.22%) 11,529,448
Mathew Chadwick 2,084,772 (10.95%) 16,957,597 (89.05%) 11,529,448

 

-Ratification of MNP LLP our independent registered public accounting firm to hold office until the close of the next annual general meeting and to allow directors to set the remuneration, approved with 30,286,680 votes For (99.07%), 285,136 votes Against (0.93%) and 1 vote Not Voted; and

-Ratification of the change of business to the regulated marijuana industry was passed with 19,029,444 votes For (99.93%), 12,925 votes Against (0.07%), and 11,529,448 Not Voted; and

-Shareholders approved the compensation of our company’s named executive officers (Say-On-Pay), by a vote of 19,008,019 votes For (99.82%), 34,350 votes Against (0.18%), and 11,554,370 Not Voted; and

-Shareholders approved a 3-year frequency (Say-When-On-Pay) of future advisory votes on the compensation of our company’s named executive officers, by the following votes One Year – 1,452,183, Two Years – 74,858 Three Years – 17,490,406, Not Voted – 11,554,370; and

-Ratification of the Company’s 2014 stock option plan was passed with 18,996,969 votes For (99.76%), 45,400 votes Against (0.24%), and 11,529,448 Not Voted.

The Company also notes that 252,000 warrants have been exercised raising $25,200 in net proceeds.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in the USA with symbol ENRT and in Canada with symbol TOP.

To learn more about Enertopia Corp. visit www.enertopia.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

InvestmentPitch Media Attending Next Gen Metal’s GreenRush Financial Conference in Seattle, Washington on September 23, 2014, Covering Medical Marijuana, Industrial Hemp and Alternative Medicines

Posted by AGORACOM-JC at 6:32 PM on Tuesday, July 22nd, 2014

Vancouver, British Columbia–(July 22, 2014) – InvestmentPitch Media will be attending the upcoming GreenRush Financial Conference in Seattle, Washington. Following very successful GreenRush Financial Conferences in Vancouver in May, and Toronto in June, arrangements are in place for the next conference which will be held on September 23rd at the Washington State Convention Centre, from 7:00 am to 5:00 pm.

For more details, please watch this video. If this link is not enabled, please visit www.InvestmentPitch.com and enter “GreenRush Conference” in the search box. InvestmentPitch is a media partner for this event, and will be available to film presentations and conduct interviews.


http://www.investmentpitch.com/video/0_wjudlxo5/InvestmentPitch-Media-Invite–GreenRush-Financial-Conference-in-Seattle-Washington–Sept-23-2014

Harry Barr, CEO, stated: “We are pleased with the results of the first two Canadian GreenRush Financial Conferences and look forward to exporting our success and brand to the United States. We would like to thank the 40+ exhibitors, 1200+ attendees and expert speakers from around the world that came together to make this Toronto conference the success that it was. We look forward to hosting our third GreenRush Financial Conference in Seattle, Washington which is the newest state to legalize recreational marijuana. Given the size of the US market, its population when compared to Canada and the fact that marijuana is legal both recreationally and medically in Washington State we anticipate that our third conference will be even bigger and better received than our conferences have been to date.”

The conference will provide a platform for venture capital investment, education and business to business opportunities, with exhibitors having a forum to showcase their products, technologies and services. For further information or to register as an attendee for the Seattle Conference, please visit www.greenrushfinancialconferences.com.

For information about further conferences, which are also being considered for North and South America as well as Europe and the Caribbean, please register on their site.

If you are interested in being a speaker, exhibitor or sponsor for the Seattle Conference please contact the GreenRush Financial Conference team at 604-685-1870 or 1-800-667-1870 or email the following:

Taylor Barr [email protected]
Ray Rich [email protected]

The GreenRush Financial Conferences are 100% owned by Next Gen Metals Inc. (CSE:N). Next Gen focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors, and is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industry.

Next Gen recently announced a non-brokered private placement of up to 3,000,000 units at $0.10 per unit, for gross proceeds of up to $300,000. For more information about Next Gen, please visit www.nextgenmetalsinc.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals,

specializes in producing short three minute videos based on significant news releases and research reports. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
[email protected]

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Toronto opens first referral-only medical marijuana clinic

Posted by AGORACOM-JC at 11:26 AM on Monday, July 21st, 2014

BLAKE WOLFE | QMI AGENCY

TORONTO – Inside a brand-new medical clinic near the intersection of Yonge St. and Eglinton Ave., a patient walks up to the counter following his appointment.

An employee stands with him, offering advice on the man’s new medication.

“Be sure to grind it well before putting consuming it,” the staffer says. “You want it fluffy like dryer lint. Fluffy is your friend when it comes to vaporizers.”

The patient thanks him for the advice and heads out the door.

It’s a normal exchange at the Cannabinoid Medical Clinic — CMClinic for short — Toronto’s first referral-only medical marijuana clinic.

It was a busy first week for executive director Dr. Danial Schecter and his staff after officially opening the clinic’s doors on July 14 and seeing dozens of the approximately 700 patients on the wait list. Talk of additional clinics in Canada is already taking place, Schecter says.

The clinic opened in the wake of new federal regulations regarding medical marijuana use. The rules, which came into effect on April 1, require that patients procure their stash from an approved supplier with a doctor’s prescription.

Schecter, who learned of marijuana’s medical effects while studying at the University of Montreal, set up the Toronto clinic after successfully using the plant to treat several patients at his former practice near Georgian Bay.

“I had a patient who suffered from anxiety so badly that he literally flapped when he walked into my office,” recalled Schecter, adding that the man self-medicated with alcohol and was afraid to consume marijuana for fear of returning to prison. “I saw his treatment as a success, and when the new regulations were announced, it was an opportunity to help many more people.”

Despite criticism from some doctors and health organizations about the lack of evidence for marijuana’s medical benefits, Schecter said he hopes to change that perception by contributing to the emerging field through his work at the clinic. He explained that in his experience, family doctors fall into three categories:

The 10% who are firmly opposed to the medical use of weed, another 10% who are open to the concept but cautious, and the 80% who are willing to prescribe it as a last resort for patients who have tried everything else.

“This is something that’s talked about for maybe five or 10 minutes in medical school,” Schecter mused. “The research done here will allow us to make a solid contribution to a novel field of medicine. I’m trying to educate the skeptical physicians and help that 80% (willing to prescribe marijuana).”

While other marijuana clinics have recently sprung up in Toronto, Schecter is quick to point out that CMClinic is referral-only and is covered through OHIP, similar to other medical specialists that a patient may be referred to by their family doctor.

Clinic spokesman Bridget Best said the facility operates more as a referral and educational centre for doctors and patients who may need assistance in learning about the various forms that cannabis can take as well as the myriad consumption methods.

Schecter said that as opposed to the typical recreational user who may consume mass quantities of weed due to tolerance of the drug, his patients often manage their pain by using less than a gram per day.

While patients are free to consume marijuana in whichever way they choose, the clinic sells vaporizers (which create marijuana vapour instead of smoke) as opposed to typical head shop fare like glass pipes and bongs.

No marijuana is stored on site, Best said.

Pursuing a medication more often associated with recreational and illicit consumption is often a last resort for most of the clinic’s patients — many of whom hail from various points across the GTA and southern Ontario, while others still have inquired from as far away as Germany and Panama.

Schecter, who said that he tries to avoid prescribing pot to anyone under 25 due to the inconclusive effects of the drug on the growing brain, deals predominantly with patients in “chronic pain,” ranging from those suffering with the lingering effects of accidents and chemotherapy to those requiring palliative care.

Travelling to the clinic from Bowmanville, patient Bob Landry recalled the 2011 traffic accident that left him with lingering pain and headaches. While Landry said that he has successfully used marijuana to treat his condition after traditional prescription drugs proved either ineffective or unthinkable, he sought out the clinic to help with proper dosages.

“I tried normal painkillers first, then my doctor offered me Oxycontin — I refused,” Landry said, explaining that his cousin had died from the controversial drug. “I believe this is the solution. I prefer to acquire it legally and, this way, I know what I’m getting.

“I hope to one day return to my normal activities.”

Source: http://www.sunnewsnetwork.ca/sunnews/canada/archives/2014/07/20140720-162102.html

Robix Appoints Former Newfoundland and Labrador Environment Minister Kevin Aylward as Strategic Advisor and Announces Shares for Debt Settlement

Posted by AGORACOM-JC at 7:20 AM on Monday, July 21st, 2014

LETHBRIDGE, ALBERTA–(July 21, 2014) – Robix Alternative Fuels Inc. (“Robix” or the “Corporation”) (CSE:RZX) announced today that it has appointed Kevin Aylward as a strategic advisor to the Corporation. Mr. Aylward has significant experience and expertise in regulatory and environmental affairs, government relations, investor relations and media relations. Having served as Minister of the Environment with the Government of Newfoundland and Labrador under Premier Brian Tobin, Mr. Aylward brings a wealth of contacts and a comprehensive understanding of the environmental issues facing the country, especially as it pertains to coastal regions. During his tenure as Minister of the Environment, the Government of Newfoundland and Labrador cultivated an offshore oil and gas industry that balanced wealth generation for the Province with preservation and protection of the ocean and Newfoundland coast. His experience has enabled him to develop extensive expertise in negotiations/mediation both in the Public and Private Sector. In addition, Mr. Alyward is currently the President and CEO/Director of NWest Energy Corporation, a TSX-V listed company.

“As a successful businessman and advocate for the environment, Kevin is very much aware of the need to balance sustainability with the ever increasing demand for energy,” commented Nathan Hansen, President and CEO. “We are delighted to welcome him as an advisor to Robix and I look forward to working with him in the coming months as we prepare to unveil our first commercial COV unit. I believe Kevin’s guidance and experience will be invaluable to the Company at this stage of our development.”

In addition, Robix intends to settle outstanding indebtedness of $510,000 through the issuance of 680,000 common shares of the Corporation at a deemed price of $0.75 per common share (the “Debt Settlement”). The common shares issued in connection with the Debt Settlement will be subject to a four month hold period.

About Robix:

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements. Robix owns a Clean Ocean Vessel (“COV”) patent, which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions. Robix has recognized a worldwide market opportunity for effective containment, recovery and disposal equipment, particularly in the oil spill protection industry, and it proposes to develop a business model as a service provider, and/or equipment provider under licensing agreements with other industry participants, wherein Robix will use its COV patented design solution.

No stock exchange or any securities regulatory body has reviewed the contents of this news release.

This news release may contain certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the company’s disclosure documents on the SEDAR website at www.sedar.com. The company does not undertake to update any forward-looking information except in accordance with applicable securities laws.

Robix Alternative Fuels Inc.
Nathan Hansen
President & CEO
250-683-8957
[email protected]

Robix Alternative Fuels Inc.
Robin Ray
Chief Financial Officer
403-327-3094
[email protected]
www.robixfuels.com

Medical Marijuana on BTV Headlining Abattis, Lexaria, Endexx, & Affinor Growers

Posted by AGORACOM-JC at 2:20 PM on Thursday, July 17th, 2014

Vancouver, British Columbia–(July 17, 2014) – BTV-Business Television goes on location to bring investors expert analyst commentary and stories on emerging companies for their portfolio.

Watch our investment show on TV and online to gain market insight: Full Episode

Please visit:
http://www.b-tv.com/the-btv-show/episodes.html?id=230

On BNN and FOX Business News Network on Sun July 20, 2014 – on National TV, BTV-Business Television showcases the following companies:

Abattis Bioceuticals Corp. (OTCQX: ATTBF) (CSE: ATT) – capitalizing on the growing trend toward marijuana legalization in the US and Canada by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and marketing support to licensed growers. Video(http://www.b-tv.com/features/watch-now.html?id=602)

Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) – BTV visits this early adapter that’s already received municipal approval in Ontario for their first medical marijuana production facility. Video (http://www.b-tv.com/features/watch-now.html?id=603)

Endexx Corp. (OTCPINK: EDXC) – supporting the cannabis industry through technology services and compliancy platforms. Video (http://www.b-tv.com/features/watch-now.html?id=604)

Affinor Growers (CSE: AFI) – automating the food production systems in Canada and the US and endeavoring to get into the medical marijuana market. Video (http://www.b-tv.com/features/watch-now.html?id=605)

And commentary from:

Alan BrochsteinAnalyst, 420Investor on what to check in cannabis companies: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_1.wmv). Cannabis trends: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_2.wmv). Technology in marijuana space: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_3.wmv). Marijuana stocks: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_4.wmv).

Horst Hueniken – President, Dundee Agricultural Corp. on medical marijuana sector: video (http://www.b-tv.com/i/videos/HorstHuenikenEp297_1.wmv). Technology in cannabis space: video (http://www.b-tv.com/i/videos/HorstHuenikenEp297_2.wmv).

BTV, a half-hour weekly business news program, profiles emerging companies across Canada and the USA to bring investors information for their portfolio. With Host Taylor Thoen, BTV features companies at their location, interviews the company’s key executives and features their business.

BTV BROADCAST TIMES:
CANADA: BNN – Sunday, July 20 @ 9:30am & 8:00pm EST
Bell Express Vu – Sunday, Jun 20 @ 9:30am & 8:00pm EST

U.S. National: Fox Business News – Sunday, July 20 @ 5:00pm EST
America One – Saturday, July 19 @ 10am EST
Biz Television Network – Thurs. Jul 24 @ 10:00pm & 1:00am EST and Sun Jul 27 @ 12:30pm, 9:00pm & 12:00am EST

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Lexaria Intends to Complete a $5,100,000 Financing

Posted by AGORACOM-JC at 8:35 AM on Thursday, July 17th, 2014

Kelowna, British Columbia–(July 17, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered convertible debenture financing, to raise gross proceeds of up to US $5,100,000. The debenture will have a term with a maturity date that is one year from the offering close.

The convertible debenture will pay 2.5% per annum simple interest, quarterly in arrears. Under certain conditions, the debenture is either refundable or, at the investor’s option may be converted into either a five-year note bearing 11% per annum simple interest or into equity of the Company at the price of US$0.30.

In connection with the convertible debenture, the Company may pay broker commissions of up to 2% cash and 8% in broker warrants exercisable at US$0.50 for a period of 12 months following closing of the Offering. Certain directors, officers and insiders of the Company may participate in the Private Placement.

Any securities issued will be subject to a hold period in Canada of four months and one day, or for any resales possible into the USA under Rule 144, six months and one day. Proceeds from the convertible debenture, under certain conditions, are to be used for corporate development in the Medical Marijuana business and G&A. The convertible debenture is subject to normal regulatory approvals.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Manager: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the proposed financing of up to $5,100,000 will be successful.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO US WIRE SERVICES. FOR CANADIAN DISTRIBUTION ONLY.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Newnote’s Revenue Generating Virtual Currency Development Service Creates Gold-Backed Crypto-Currency for Anthem Vault Inc.

Posted by AGORACOM-JC at 9:08 AM on Wednesday, July 16th, 2014

Vancouver, British Columbia – Newnote Financial Corp. (the “Company” or “Newnote”) (CSE: NEU; FSE: 1W4) is pleased to announce the successful development and launch of the first open-source gold-backed alternative crypto-currency, commissioned by Anthem Vault Inc. Anthem Vault is a leading technological innovator in the bullion markets and precious metals dealer offering fractional investment in one-kilo gold bars and COMEX-approved 1,000 oz. silver bars.

As one of the leaders in the crypto-currency sector, Newnote specializes in the custom development of virtual currencies based on the criteria and specific needs of its clients. Newnote can be retained to develop new digital currencies which include a full range of utilities such as Linux, Windows, Mac OSX and Android Wallets and Block Chain ledger for tracking transactions. Newnote offers complete end-to-end consulting, development, deployment and maintenance of the client‘s new digital currency as well as a listing on our proprietary trading platform if requested.

Anthem Vault announced The INNCoin (IndependenceCoin) at FreedomFest 2014, which was held in Las Vegas, Nevada, USA. INNcoin is just the latest example of new technology being deployed in innovative fashion to facilitate easier ownership, storage and transfer of precious metals in commerce. The virtual currency was secretly launched on the 4th of July 2014 by Anthem Vault’s technology team, in conjunction with Newnote Financial Corp. Dubbed the 4th of July Coin, this first Anthem Vault alt-coin is commonly referred to as MGC (Micro Gold Coin).

The MGC is an open source crypto-currency which means any person can download and look at the source code behind the coin, which is similar to Bitcoin. However, the coin has some unique attributes which sets it apart from Bitcoin. For example, there will only be a total of 10 million MGC’s in this series. All coins will be fully mined within one year, meaning all 10 million MGC’s will be in circulation and/or ownership by July of 2015. The entire series of MGC’s are backed by 100 grams of Gold stored at Anthem Vault, providing a base value to all MGC’s from the first moment the coins are “mined”.

An Anthem Vault account is free to create and there is no obligation to make a purchase. Creating an account is currently the only way to obtain an Anthem Vault MGC wallet to hold this new crypto-currency. Each AV wallet also contains mining software to allow even the most novice user the ability to download the wallet and mine / produce MGC’s right from their computer. This experimental currency is being used to demonstrate how gold or any precious metal can back a crypto-currency and become a truly independent commerce solution.

Anthem Hayek Blanchard, Anthem Vault CEO and Founder states: “This coin stands for currency independence and demonstrates the use of crypto-currencies as micro-gold weighted instruments in commerce.”

Paul Dickson, President and CEO of Newnote states: “We are very pleased Anthem Vault Inc. chose Newnote to develop this coin. A gold-backed crypto-currency is an important milestone in the evolution of digital currencies and enabled us to demonstrate our technical ability to create asset backed virtual currencies. We believe this division of our business will significantly contribute to our revenue model moving forward.”

About Newnote Financial Corp.

Newnote Financial Corp. is pioneering innovative crypto-currency and Bitcoin related software products and services geared at the growing business segment of this bourgeoning market. Newnote has positioned itself to be a leading contender in delivering opportunities to startup businesses world-wide and continues to create new opportunities for its clients and its shareholders. Newnote has a clear vision on the direction in which this new and unique business is headed and is continually adjusting and adopting new business practices in both technology and the policies & procedures required by banks and securities regulators.

About Anthem Vault

Anthem Vault is a precious metals dealer offering fractional investment in one-kilo (32.15 oz. .9999 fine) gold bars and COMEX-approved 1,000 oz. (.9990 fine or higher) silver bars. All bars are assayed by globally recognized LBMA-approved refiners.

All metal is vaulted in an independent professional world-class facility in Salt Lake City, UT and is insured against theft and natural disaster by Lloyd’s of London. Anthem Vault is the only U.S.-based company that offers the ability to buy metal by direct deposit (ACH/EFT), wire transfer, and Bitcoin.

Anthem Vault (lead by Anthem Hayek Blanchard, eldest son of James U. Blanchard, III) continues to carry forth a legacy of trust, professionalism and innovation as it leads the global bullion dealer industry in technological innovations, providing for greater liquidity and fungibility. www.anthemvault.com

For further information please contact:

Paul Dickson

President, CEO & Director

Newnote Financial Corp.

Suite 709-700 West Pender Street

Vancouver, BC V6C 1G8

direct: 604-229-0480

fax: 604-685-3833

web: www.newnote.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of Newnote Financial Corp. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

Next Gen Announces 3rd GreenRush Financial Conference in Seattle, Washington on Tuesday, September 23rd; Invites Investors and Exhibitors to Attend

Posted by AGORACOM-JC at 8:40 AM on Tuesday, July 15th, 2014

-Following the initial GreenRush Financial Conference in Vancouver, the first Toronto GreenRush Financial Conference exceeded expectations

-Over 1,200 attendees

-Over 40 exhibitors

-Expert speakers from across North America

-Extensive Media coverage from the major outlets across Canada

-GreenRush goes international with the third conference being held in Seattle, Washington on September 23, 2014 at the Washington State Convention Centre – Level 600

-Further conferences are also being considered throughout North and South America as well as Europe and the Caribbean. For further information and to register as an attendee for the Seattle Conference, please visit our websites at www.greenrushfinancialconferences.com and www.nextgenmetalsinc.com

-GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (CSE-N, OTC-PK NXTTF, FSE-M5BN) and its stated objective is to be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

-Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage, consultancy solutions and a facilitator for the above mentioned industries

Vancouver, British Columbia, Canada / TNW-ACCESWIRE / July 15, 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that its second GreenRush Financial Conference held in Toronto, Ontario exceeded expectations and continues to establish the GreenRush Financial Conferences as the premier investment/business conference in the Industry. Next Gen also formally invites interested investors, industry participants, stakeholders and exhibitors to our third and first international GreenRush Financial Conference being held in Seattle, Washington on September 23, 2014.

Harry Barr, CEO, stated that, “We are pleased with the results of the first two Canadian GreenRush Financial Conferences and look forward to exporting our success and brand to the United States. We would like to thank the 40+ exhibitors, 1200+ attendees and expert speakers from around the world that came together to make this Toronto conference the success that it was. We look forward to hosting our third GreenRush Financial Conference in Seattle, Washington which is the newest state to legalize recreational marijuana. Given the size of the US market, its population when compared to Canada and the fact that marijuana is legal both recreationally and medically in Washington State we anticipate that our third conference will be even bigger and better received than our conferences have been to date.”

If you are interested in being a speaker, exhibitor or sponsor for the Seattle Conference please submit your indication of interest as soon as possible to the GreenRush Financial Conference team below as it is selling out quickly.

For more information on GreenRush Conferences please visit our website at

www.greenrushfinancialconferences.com, email our Conference Coordinators at [email protected], or contact us by phone at (604) 685-1870

 

Click Image To View Full Size

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided  an  opportunity  for  the  company  to  enter  into  this  emerging  multi-billion  dollar  industry.  Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries.

Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangements to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industries.  For further information on the company, visit our website at www.nextgenmetalsinc.com .

On March 20, 2014 Next Gen Metals announced that it had established its first wholly owned subsidiary, a Conference Division that intends to host Canada’s first conferences focused on business to business opportunities, the investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Financial Conferences’ vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

If you are interested in being a speaker, exhibitor or sponsor for future Financial Conferences please submit your indication of specific interest as soon as possible to the GreenRush Financial Conference team as the available spaces are fill up quickly.

On May 6, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories vision is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.

Next Gen’s Management’s intention is to invest in a basket of companies within these growing industries. The company’s business model continues to generate new business plans and project submittals 24/7. In light of Next Gen’s vision, Management is evaluating multiple new business plans and industry related proposals on an ongoing basis.  To that end, on June 23rd 2014 Next Gen Formed a Business Unit called GreenRush Business Brokerage who’s vision is to introduce business to business opportunities, complete transactions and for this unit be an additional profit centre for Next Gen.

Next Gen continues to receive  and  review  numerous  proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation,  education,  Brokerage and Consultancy Solutions, Public  awareness,  specialty  clinics  and  ancillary  business  opportunities.  The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

Next Gen’s Corporate Structure

Click Image To View Full Size

Click Image To View Full Size

For more information on GreenRush Conferences please visit our website at www.greenrushfinancialconferences.com, email us at [email protected] or contact us by phone at (604) 685-1870.

About GreenRush Financial Conferences

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (Public Company, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

We would also like to invite the participants, attendees, keynote speakers, industry and investment experts all to attend to our next conferences which are slated for the Seattle, WA-Fall 2014 with additional conferences in Calgary, Edmonton, Montreal, other US cities and Europe in 2014-2015

Investors and other interested parties are invited to attend and learn about investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine business sector

Click Image To View Full Size

About GreenRush Analytical Laboratories Inc.:

GreenRush Laboratories (GAL) is Next Gen’s fully owned subsidiary providing Analytical Analysis for medical-grade cannabis products. GAL will seek to become a certified Analytical Laboratory under the new Marijuana for Medical Purposes Regulations (MMPR) and will establish analytical laboratories equipped to provide product analysis and micro propagation and other professional services to Licensed Producers, distributers, caregivers and Industrial Hemp farmers.

Our goal is to provide analytical testing to the cannabis industry to ensure the health and safety of consumers and to maximize the quality of our client’s products.

For further information on GreenRush Analytical Laboratories Inc. please visit us at http://www.greenrushanalyticallabs.com/

 

Click Image To View Full Size

About GreenRush Business Brokerage

GreenRush Business Brokerage (GBB)

GreenRush Business Brokerage (GBB) is a business brokerage and advisory and consultancy business unit of Next Gen (CSE: N, OTC Pink: NXTTF, FSE: M5BN), GBB is headquartered in Vancouver, British Columbia with satellite offices in Toronto and Rockport, Ontario, and Maui county, Hawaii, USA. GreenRush Business Brokerage unit serves as an intermediary between buyers and sellers of small to medium-size businesses across the Medical Marijuana, Industrial Hemp and Alternative medicine industries.

For further information on GreenRush Business Brokerage Unit please visit us at www.nextgenmetalsinc.com

On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release

Municipal Approval for Lexaria-Enertopia Joint Venture in Burlington, Ontario

Posted by AGORACOM-JC at 7:34 AM on Monday, July 14th, 2014

Kelowna, British Columbia–(Newsfile Corp. – July 14, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria“) is pleased to announce that the production of Medical Marihuana in compliance with Health Canada MMPR regulations has received final Municipal zoning approval for the Lexaria/Enertopia joint venture. Previously announced only as being located in the Greater Toronto Area, now that Municipal approval has been obtained Lexaria is happy to announce the facility location as Burlington, Ontario.

The evaluation procedures of the City of Burlington were followed, including presentations made to city officials and opportunities for public feedback and input. Lexaria is pleased that the City of Burlington showed community leadership and vision in implementing a thoughtful series of rules for the cultivation of medical marijuana in accordance with Federal Health Canada regulations.

“Approval by the City of Burlington for a medical marijuana production facility is an important step in the journey towards our goal of obtaining a license under Health Canada’s MMPR program and becoming a leader in the industry,” said Chris Bunka, CEO of Lexaria Corp.

Now that the City of Burlington has passed a bylaw permitting medical marijuana production facilities, Lexaria expects that the joint venture license application to Health Canada will be submitted soon.

The bylaw approving the medical marijuana facility zoning was passed by Burlington officials on June 9th, and the period of time when appeals were allowed to be heard expired on July 9, 2014. Notice of passing of the Bylaw was provided on July 10, and at this time the bylaw is in existence.

The Lexaria/Enertopia joint venture, as previously reported, is for a building of approx 30,000 sq ft for first phase design, with a right of first refusal obtained for approx another 45,000 sq ft. Since the original announcement of this facility on April 10, 2014, a great deal of progress has been made regarding the state of the art design concepts expected to be implemented.

The joint venture has engaged David Hyde & Associates for security design and implementation. David Hyde & Associates is a full service security management and business risk consulting and training practice that offers independent, high quality advisory services underpinned by real-world security and risk management experience. David Hyde & Associates, widely acknowledged as one of Canada’s leading security experts, has previously been a security consultant to another existing company that has already received their license under the MMPR program.

The joint venture has also engaged KNY Architects Inc, a design and planning firm headquartered in Burlington that has been in business for over 55 years. They have completed hundreds of projects across Canada, USA, and the Ukraine.

A total of 880,000 restricted common shares will be issued to a number of persons in accordance with previously entered agreements, upon reaching the municipal approval milestone. The securities issued will be subject to a hold period in Canada of four months and one day, or for any resales possible into the USA under Rule 144, six months and one day.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Separately, Lexaria has accepted the resignation of Chris Hornung as Assistant Operations Manager.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp. Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Inquiries: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria, and no assurance that any proposed new facility will be built or proceed, nor that municipal or Health Canada regulatory approvals will be obtained. There is no assurance that any municipality where proposed facilities are located will retain its approval for a medical marijuana production facility. The Company is not currently growing or selling medical marijuana.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks